Clinical Research Directory
Browse clinical research sites, groups, and studies.
Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye
Sponsor: Iran University of Medical Sciences
Summary
The purpose of this study is to determine the safety and efficacy of Limbal Stem Cells derived Exosomes (LSC-Exo) in alleviation of dry eye symptoms
Official title: A Clinical Study for Safety and Efficacy Evaluation of Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye Syndrome
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2024-08-01
Completion Date
2026-07-01
Last Updated
2025-05-01
Healthy Volunteers
No
Conditions
Interventions
Limbal Stem Cell Derived Exosomes Eye Drop
Patients will receive artificial tears for 2 weeks to get the normalized baseline, followed by LSC-Exo eye drops 0.15 ml/single eye/one time, four times a day for 3 months. The follow-up visit will be 12 weeks since the administration of LSC-Exo eye drops.
Locations (1)
Moheb Kowsar Hospital
Tehran, Iran